Literature DB >> 33584328

PET Imaging of Dopamine Neurotransmission During EEG Neurofeedback.

Tomas Ros1,2, Jessica Kwiek1,3, Theo Andriot1, Abele Michela1, Patrik Vuilleumier1, Valentina Garibotto4, Nathalie Ginovart1,3.   

Abstract

Neurofeedback (NFB) is a brain-based training method that enables users to control their own cortical oscillations using real-time feedback from the electroencephalogram (EEG). Importantly, no investigations to date have directly explored the potential impact of NFB on the brain's key neuromodulatory systems. Our study's objective was to assess the capacity of NFB to induce dopamine release as revealed by positron emission tomography (PET). Thirty-two healthy volunteers were randomized to either EEG-neurofeedback (NFB) or EEG-electromyography (EMG), and scanned while performing self-regulation during a single session of dynamic PET brain imaging using the high affinity D2/3 receptor radiotracer, [18F]Fallypride. NFB and EMG groups down-regulated cortical alpha power and facial muscle tone, respectively. Task-induced effects on endogenous dopamine release were estimated in the frontal cortex, anterior cingulate cortex, and thalamus, using the linearized simplified reference region model (LSRRM), which accounts for time-dependent changes in radiotracer binding following task initiation. Contrary to our hypothesis of a differential effect for NFB vs. EMG training, significant dopamine release was observed in both training groups in the frontal and anterior cingulate cortex, but not in thalamus. Interestingly, a significant negative correlation was observed between dopamine release in frontal cortex and pre-to-post NFB change in spontaneous alpha power, suggesting that intra-individual changes in brain state (i.e., alpha power) could partly result from changes in neuromodulatory tone. Overall, our findings constitute the first direct investigation of neurofeedback's effect on the endogenous release of a key neuromodulator, demonstrating its feasibility and paving the way for future studies using this methodology.
Copyright © 2021 Ros, Kwiek, Andriot, Michela, Vuilleumier, Garibotto and Ginovart.

Entities:  

Keywords:  Fallypride; dopamine; electroencephalography; electromyography; neurofeedback; positron emission tomography

Year:  2021        PMID: 33584328      PMCID: PMC7873858          DOI: 10.3389/fphys.2020.590503

Source DB:  PubMed          Journal:  Front Physiol        ISSN: 1664-042X            Impact factor:   4.566


  67 in total

1.  Paradox lost? Exploring the role of alpha oscillations during externally vs. internally directed attention and the implications for idling and inhibition hypotheses.

Authors:  Nicholas R Cooper; Rodney J Croft; Samuel J J Dominey; Adrian P Burgess; John H Gruzelier
Journal:  Int J Psychophysiol       Date:  2003-01       Impact factor: 2.997

2.  Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.

Authors:  Jogeshwar Mukherjee; Bradley T Christian; Kelly A Dunigan; Bingzhi Shi; Tanjore K Narayanan; Martin Satter; Joseph Mantil
Journal:  Synapse       Date:  2002-12-01       Impact factor: 2.562

Review 3.  Neocortical dynamics: implications for understanding the role of neurofeedback and related techniques for the enhancement of attention.

Authors:  J F Lubar
Journal:  Appl Psychophysiol Biofeedback       Date:  1997-06

4.  PET parametric imaging improved by global-two-stage method.

Authors:  Giampaolo Tomasi; Alessandra Bertoldo; Claudio Cobelli
Journal:  Ann Biomed Eng       Date:  2008-12-12       Impact factor: 3.934

Review 5.  Enhanced Responsiveness and Low-Level Awareness in Stochastic Network States.

Authors:  Yann Zerlaut; Alain Destexhe
Journal:  Neuron       Date:  2017-06-07       Impact factor: 17.173

6.  Endogenous control of waking brain rhythms induces neuroplasticity in humans.

Authors:  Tomas Ros; Moniek A M Munneke; Diane Ruge; John H Gruzelier; John C Rothwell
Journal:  Eur J Neurosci       Date:  2010-02       Impact factor: 3.386

7.  Intact striatal dopaminergic modulation of reward learning and daily-life reward-oriented behavior in first-degree relatives of individuals with psychotic disorder.

Authors:  Zuzana Kasanova; Jenny Ceccarini; Michael J Frank; Thérèse van Amelsvoort; Jan Booij; Esther van Duin; Henrietta Steinhart; Thomas Vaessen; Alexander Heinzel; Felix Mottaghy; Inez Myin-Germeys
Journal:  Psychol Med       Date:  2017-12-13       Impact factor: 7.723

Review 8.  Plastic corticostriatal circuits for action learning: what's dopamine got to do with it?

Authors:  Rui M Costa
Journal:  Ann N Y Acad Sci       Date:  2007-04-13       Impact factor: 5.691

9.  Human anterior cingulate neurons and the integration of monetary reward with motor responses.

Authors:  Ziv M Williams; George Bush; Scott L Rauch; G Rees Cosgrove; Emad N Eskandar
Journal:  Nat Neurosci       Date:  2004-11-21       Impact factor: 24.884

Review 10.  The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes.

Authors:  Robert M Bilder; Jan Volavka; Herbert M Lachman; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2004-11       Impact factor: 7.853

View more
  3 in total

1.  Alpha/Theta Ratio Neurofeedback Training for Attention Enhancement in Normal Developing Children: A Brief Report.

Authors:  Wenya Nan; Mengqi Wan; Yali Jiang; Xiaoping Shi; Feng Wan; Dan Cai
Journal:  Appl Psychophysiol Biofeedback       Date:  2022-06-13

Review 2.  Neurofeedback and neural self-regulation: a new perspective based on allostasis.

Authors:  Arash Mirifar; Andreas Keil; Felix Ehrlenspiel
Journal:  Rev Neurosci       Date:  2022-02-07       Impact factor: 4.703

3.  Frontostriatal circuitry as a target for fMRI-based neurofeedback interventions: A systematic review.

Authors:  Linda Orth; Johanna Meeh; Ruben C Gur; Irene Neuner; Pegah Sarkheil
Journal:  Front Hum Neurosci       Date:  2022-08-24       Impact factor: 3.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.